Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy

Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy

Purpose: To compare the choriocapillaris vessel density between intravitreal ranibizumab (Lucentis) (IVR) plus photodynamic therapy (PDT) and intravitreal aflibercept (Eylea) (IVA) monotherapy in patients experiencing polypoidal choroidal vasculopathy (PCV). Design: An observational, retrospective c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Po-Chin Kuo, Sheng-Min Hsu, Yi-Hsun Huang, Chun-Hsiang Chang, Yi-Sheng Chang, Jia-Horung Hung, Chun-Chieh Lai, Yu-Kuei Lee
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Photodiagnosis and Photodynamic Therapy
Subjects:	Anti-VEGF Choriocapillaris vessel density Optical coherence tomography angiography Photodynamic therapy Polypoidal choroidal vasculopathy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1572100025000614
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01)

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment
by: Lulu Chen, et al.
Published: (2025-07-01)

Research status of clinicopathologic studies of polypoidal choroidal vasculopathy
by: LI Miaoling, et al.
Published: (2025-02-01)

A case of treating polypoidal choroidal vasculopathy subretinal fluid by subthreshold micropulse laser
by: Sarmad Mustafa Jafar, et al.
Published: (2024-12-01)

Polypoidal choroidal vasculopathy with an exceptionally elevated pigment epithelial detachment
by: Yanliang Li, et al.
Published: (2024-12-01)

Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review
by: Adriono GA, et al.
Published: (2025-03-01)

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases &ndash; The FAR-PEARL Study Report 1
by: Fong KC, et al.
Published: (2025-07-01)

Age-Related Scattered Hypofluorescent Spots as an Adverse Prognostic Factor for Polypoidal Choroidal Vasculopathy
by: Seo Hee Kim, MD, et al.
Published: (2025-09-01)

Spontaneous resolution of photodynamic therapy-induced acute exudative maculopathy in a patient suffering from polypoidal choroidal vasculopathy: A case report with 3-year follow-up
by: Alexandros Rouvas, et al.
Published: (2025-01-01)

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy
by: Tavonvunchai F, et al.
Published: (2025-06-01)

Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study
by: Tsung-I. Wang, et al.
Published: (2025-06-01)

Effects of orthokeratology lenses on choroidal thickness and choriocapillaris perfusion in myopic children
by: Lulu Wang, et al.
Published: (2025-08-01)

Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies.
by: Wei Wang, et al.
Published: (2014-01-01)

Analysis of choriocapillaris vascular density in patients with retinitis pigmentosa caused by RPGR gene mutations
by: Carlo Gesualdo, et al.
Published: (2025-07-01)

Anti-VEGF combined with fufang xueshuangtong versus anti-VEGF monotherapy for wet age-related macular degeneration: A meta-analysis
by: Tingke Xie, et al.
Published: (2025-06-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

The Effects of VEGF Signal Pathway on Etiopathogenesis and AntiVEGF Treatments in Childhood Cancers
by: Ali Kazdal, et al.
Published: (2023-09-01)

Metabolomics analysis uncovers metabolic changes and remodeling of anti-VEGF therapy on macular edema
by: Congcong Yan, et al.
Published: (2025-07-01)

Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
by: Mohan S, et al.
Published: (2025-01-01)

Idiopathic polypoidal choroidal vasculopathy
by: Cekić Sonja, et al.
Published: (2012-01-01)

Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
by: Mousumi Banerjee, et al.
Published: (2025-06-01)

Noninvasive Polypoid Malignant Mixed Mullerian Tumor of the Uterus: A Case Report and Literature Review
by: Leon Kaza, et al.
Published: (2025-01-01)

Radiologic findings of polypoid pyeloureteritis: a case report
by: Michael Phillipi, BA, et al.
Published: (2025-04-01)

Histological changes of endocervical polypoid lesions in women at reproductive age
by: Muna Zuhair Al-Hamdany, et al.
Published: (2024-01-01)

Effects of a 24-week yoga intervention on choriocapillaris density in Parkinson’s disease
by: Lei Wan, et al.
Published: (2025-01-01)

Polypoidal Choroidal Vasculopathy in Congolese Patients
by: Nelly N. Kabedi, et al.
Published: (2020-01-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Fertility-sparing treatment for atypical polypoid adenomyoma
by: Isabel Beshar, et al.
Published: (2025-04-01)

Assessment of choriocapillary flow deficits in myopic children by optical coherence tomography angiography
by: Fangyuan Zhou, et al.
Published: (2025-05-01)

Clinical implication of aberrant choroidal feeding artery in type 1 macular neovasculopathy
by: Hyun Seung Yang, et al.
Published: (2025-05-01)

Novel anti-VEGF scFv antibodies with superior in vitro and in vivo activities
by: Gulcin Cakan-Akdogan, et al.
Published: (2025-07-01)

IMMUNE PARAMETERS AND NASAL MICROFLORA IN PATIENTS WITH POLYPOID RHINOSINUSITIS AND ASTHMATIC TRIAD
by: A. M. Lapteva, et al.
Published: (2016-12-01)

A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
by: Robert Hodgson, et al.
Published: (2025-01-01)

Plasma levels of the lymphangiogenic factors VEGF-C, VEGF-D, and CXCL-12 are elevated in advanced diabetic nephropathy
by: Qingshan Tian, et al.
Published: (2025-12-01)

Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections
by: Shinji Kakihara, MD, PhD, et al.
Published: (2025-05-01)

Analysis of cytokine profiles in aqueous humor based on optical coherence tomography in pachychoroid spectrum diseases
by: Caiyun Zhang, et al.
Published: (2025-07-01)

Next-Generation Long-Acting Anti-VEGF Therapies for the Treatment of Diabetic Macular Edema
by: Piotr Rzyczniok, et al.
Published: (2025-04-01)

Six Cases of Polypoidal Choroidal Vasculopathy in Eyes with Choroidal Nevi
by: Andrea Gaggino, et al.
Published: (2025-02-01)

Polypoid endometriosis—An exceptional subtype of endometriosis mimicking an aggressive pelvic cancer
by: Katia Mahiou, et al.
Published: (2024-09-01)

Cardiac allograft vasculopathy: current review
by: B. L. Mironkov, et al.
Published: (2024-07-01)